147 related articles for article (PubMed ID: 20617160)
1. Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.
Fung EB; Johnson JA; Madden J; Kim T; Harmatz P
J Pediatr Rehabil Med; 2010; 3(1):13-23. PubMed ID: 20617160
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone health in patients with mucopolysaccharidosis.
Kor D; Bulut FD; Kılavuz S; Şeker Yılmaz B; Köşeci B; Kara E; Kaya Ö; Başaran S; Seydaoğlu G; Önenli Mungan N
J Bone Miner Metab; 2022 May; 40(3):498-507. PubMed ID: 35066680
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in patients with mucopolysaccharidosis type III.
Nur BG; Nur H; Mihci E
J Bone Miner Metab; 2017 May; 35(3):338-343. PubMed ID: 27193466
[TBL] [Abstract][Full Text] [Related]
4. Low bone mineral content and challenges in interpretation of dual-energy X-ray absorptiometry in children with mucopolysaccharidosis types I, II, and VI.
Polgreen LE; Thomas W; Fung E; Viskochil D; Stevenson DA; Steinberger J; Orchard P; Whitley CB; Ensrud KE
J Clin Densitom; 2014; 17(1):200-6. PubMed ID: 23562131
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in mucopolysaccharidosis IVB.
Kubaski F; Kecskemethy HH; Harcke HT; Tomatsu S
Mol Genet Metab Rep; 2016 Sep; 8():80-84. PubMed ID: 27699153
[TBL] [Abstract][Full Text] [Related]
6. Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses.
Lin HY; Shih SC; Chuang CK; Chen MR; Niu DM; Lin SP
Orphanet J Rare Dis; 2013 May; 8():71. PubMed ID: 23663302
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry.
Turner AS; Norrdin RW; Gaarde S; Connally HE; Thrall MA
Calcif Tissue Int; 1995 Sep; 57(3):191-5. PubMed ID: 8574935
[TBL] [Abstract][Full Text] [Related]
8. Radiographic Findings of Mucopolysaccharidosis and Comparison with Bone Mineral Density: A Study from Southeastern Turkey.
Ayaz E; Bozaci AE
J Clin Densitom; 2022; 25(4):475-484. PubMed ID: 36100508
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in MPS IV A (Morquio syndrome type A).
Kecskemethy HH; Kubaski F; Harcke HT; Tomatsu S
Mol Genet Metab; 2016 Feb; 117(2):144-9. PubMed ID: 26670863
[TBL] [Abstract][Full Text] [Related]
10. Should 25-hydroxyvitamin D and bone density using DXA be tested in adolescents with lumbar stress fractures of the pars interarticularis?
McClellan JW; Vernon BA; White MA; Stamm S; Ryschon KL
J Spinal Disord Tech; 2012 Dec; 25(8):426-8. PubMed ID: 22134731
[TBL] [Abstract][Full Text] [Related]
11. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
[TBL] [Abstract][Full Text] [Related]
12. Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data.
Simmons JH; Rush ET; Petryk A; Zhou S; Martos-Moreno GÁ
Bone; 2020 Aug; 137():115413. PubMed ID: 32417537
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation.
Caetano M; Terreri MT; Ortiz T; Pinheiro M; Souza F; Sarni R
Clin Rheumatol; 2015 Dec; 34(12):2065-70. PubMed ID: 26227163
[TBL] [Abstract][Full Text] [Related]
14. Bone health of children with intestinal failure measured by dual energy X-ray absorptiometry and digital X-ray radiogrammetry.
Neelis E; Rijnen N; Sluimer J; Olieman J; Rizopoulos D; Wijnen R; Rings E; de Koning B; Hulst J
Clin Nutr; 2018 Apr; 37(2):687-694. PubMed ID: 28274657
[TBL] [Abstract][Full Text] [Related]
15. Low bone mineral density in adults with cystic fibrosis.
Haworth CS; Selby PL; Webb AK; Dodd ME; Musson H; McL Niven R; Economou G; Horrocks AW; Freemont AJ; Mawer EB; Adams JE
Thorax; 1999 Nov; 54(11):961-7. PubMed ID: 10525552
[TBL] [Abstract][Full Text] [Related]
16. Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10-year prospective study.
Miller BS; Fung EB; White KK; Lund TC; Harmatz P; Orchard PJ; Whitley CB; Polgreen LE
J Inherit Metab Dis; 2023 Jul; 46(4):695-704. PubMed ID: 36840680
[TBL] [Abstract][Full Text] [Related]
17. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
Frost ML; Blake GM; Fogelman I
J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
19. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
[TBL] [Abstract][Full Text] [Related]
20. Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography.
Leonard MB; Shults J; Elliott DM; Stallings VA; Zemel BS
Bone; 2004 Jun; 34(6):1044-52. PubMed ID: 15193552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]